Skip to main content
PRTA logo

Prothena Corporation plc

PRTANASDAQHealthcareBiotechnology

$8.40Today:- (-)1Y −15.49%

As of Oct 26, 2026 close

Market cap
$438.02M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$7.73$11.80
Volume (live)
-
Avg. volume (3M)
560.20K

Prothena Corporation (PRTA) Income Statement

Prothena Corporation reported revenue of $9.68M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 92.8% from $135.16M a year earlier. Prothena Corporation posted a net loss of $244.09M, compared with a net loss of $122.31M a year earlier. Gross margin was 100.0% and operating margin -2216.4%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $1.01M, down 77.1% from the same quarter a year earlier.

Prothena Corporation Income Statement Analysis

Values in millions USD

Scroll to see more
Prothena Corporation plc income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue9.68135.1691.3753.91200.580.850.810.9627.52
Cost of Revenue134.85222.520.00135.560.0074.8850.84101.18134.55
Gross Profit9.68135.1691.3753.91200.58-74.03-50.02-100.23-107.03
Operating Expenses
Research & Development134.85222.52220.57135.5682.2875.0950.84101.18134.55
Selling, General & Administrative59.3967.2061.8449.9046.3238.7035.7442.4848.23
Operating Expenses224.32289.72282.41185.46128.6038.7035.68143.67182.77
Operating Income-214.64-154.56-191.04-131.5671.98-112.73-85.70-158.86-155.25
Other Income/Expense
Interest Income14.1425.8231.016.350.041.378.206.393.55
Interest Expense0.000.000.000.000.000.000.003.703.69
Other Income/Expense13.8125.63-0.46-0.40-0.101.878.402.74-2.35
Income
Income Before Tax-200.83-128.93-160.48-125.6171.92-110.86-77.30-156.12-157.60
Income Tax Expense43.26-6.62-13.45-8.664.950.280.38-0.47-4.37
Net Income-244.09-122.31-147.03-116.9566.98-111.14-77.68-155.65-153.24
Net Income - Continuous Operations-244.09-122.31-147.03-116.9566.98-111.14-77.68-155.65-153.24
Net Income - Discontinued Operations---------
EBITDA-183.67-153.67-190.11-130.8173.09-111.22-84.19-152.90-152.19
EBIT-184.56-154.56-191.04-131.5671.98----
Depreciation & Amortization0.900.890.930.741.121.511.563.223.07
Earnings Per Share
Basic EPS-5.00-2.00-3.00-2.002.00-3.00-2.00-4.00-4.00
Diluted EPS-5.00-2.00-3.00-2.001.00-3.00-2.00-4.00-4.00
Basic Shares Outstanding53.8353.7753.2247.3744.2339.9239.8839.5637.65
Diluted Shares Outstanding53.8353.7753.2247.3748.4639.9239.8839.5637.65

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Prothena Corporation Financial Statements

What was Prothena Corporation's revenue in fiscal 2025?

Prothena Corporation reported revenue of $9.68M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 92.8% from $135.16M a year earlier.

Is Prothena Corporation profitable?

No. Prothena Corporation reported a net loss of $244.09M in fiscal 2025. In fiscal 2024 it lost $122.31M.

What is Prothena Corporation's operating margin?

Prothena Corporation's operating income was −$214.64M on revenue of $9.68M in fiscal 2025, an operating margin of -2216.4%, compared with -114.4% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition